Single-Dose Lignocaine-Based Blood Cardioplegia in Single Valve Replacement Patients
AUTOR(ES)
Ramani, Jaydip, Malhotra, Amber, Wadhwa, Vivek, Sharma, Pranav, Garg, Pankaj, Tarsaria, Malkesh, Pandya, Himani
FONTE
Braz. J. Cardiovasc. Surg.
DATA DE PUBLICAÇÃO
2017-04
RESUMO
Abstract OBJECTIVE: Myocardial protection is the most important in cardiac surgery. We compared our modified single-dose long-acting lignocaine-based blood cardioplegia with short-acting St Thomas 1 blood cardioplegia in patients undergoing single valve replacement. METHODS: A total of 110 patients who underwent single (aortic or mitral) valve replacement surgery were enrolled. Patients were divided in two groups based on the cardioplegia solution used. In group 1 (56 patients), long-acting lignocaine based-blood cardioplegia solution was administered as a single dose while in group 2 (54 patients), standard St Thomas IB (short-acting blood-based cardioplegia solution) was administered and repeated every 20 minutes. All the patients were compared for preoperative baseline parameters, intraoperative and all the postoperative parameters. RESULTS: We did not find any statistically significant difference in preoperative baseline parameters. Cardiopulmonary bypass time were 73.8±16.5 and 76.4±16.9 minutes (P=0.43) and cross clamp time were 58.9±10.3 and 66.3±11.2 minutes (P=0.23) in group 1 and group 2, respectively. Mean of maximum inotrope score was 6.3±2.52 and 6.1±2.13 (P=0.65) in group 1 and group 2, respectively. We also did not find any statistically significant difference in creatine-phosphokinase-MB (CPK-MB), Troponin-I levels, lactate level and cardiac functions postoperatively. CONCLUSION: This study proves the safety and efficacy of long-acting lignocaine-based single-dose blood cardioplegia compared to the standard short-acting multi-dose blood cardioplegia in patients requiring the single valve replacement. Further studies need to be undertaken to establish this non-inferiority in situations of complex cardiac procedures especially in compromised patients.
Documentos Relacionados
- Single-Dose Del Nido Cardioplegia vs. Blood Cardioplegia in Aortic Valve Replacement Surgery
- Single-dose pharmacokinetics of aztreonam in pediatric patients.
- Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
- Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.
- Single-dose ceftriaxone for chancroid.